| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |